128 related articles for article (PubMed ID: 29568907)
1. Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells.
Fallahi P; Foddis R; Elia G; Ragusa F; Patrizio A; Frenzilli G; Benvenga S; Cristaudo A; Antonelli A; Ferrari SM
Mol Med Rep; 2018 May; 17(5):7415-7420. PubMed ID: 29568907
[TBL] [Abstract][Full Text] [Related]
2. CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide.
Fallahi P; Foddis R; Elia G; Ragusa F; Patrizio A; Benvenga S; Cristaudo A; Antonelli A; Ferrari SM
Mol Med Rep; 2018 Aug; 18(2):1798-1803. PubMed ID: 29901202
[TBL] [Abstract][Full Text] [Related]
3. Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells.
Fallahi P; Foddis R; Elia G; Ragusa F; Patrizio A; Benvenga S; Cristaudo A; Antonelli A; Ferrari SM
Oncol Rep; 2018 May; 39(5):2422-2426. PubMed ID: 29517108
[TBL] [Abstract][Full Text] [Related]
4. Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide.
Fallahi P; Foddis R; Elia G; Ragusa F; Patrizio A; Guglielmi G; Frenzilli G; Benvenga S; Cristaudo A; Antonelli A; Ferrari SM
Mol Med Rep; 2018 May; 17(5):6914-6918. PubMed ID: 29532885
[TBL] [Abstract][Full Text] [Related]
5. Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists.
Antonelli A; Ferrari SM; Mancusi C; Mazzi V; Pupilli C; Centanni M; Ferri C; Ferrannini E; Fallahi P
Immunobiology; 2013 May; 218(5):690-5. PubMed ID: 22944249
[TBL] [Abstract][Full Text] [Related]
6. Interferon-γ and tumor necrosis factor-α sustain secretion of specific CXC chemokines in human thyrocytes: a first step toward a differentiation between autoimmune and tumor-related inflammation?
Rotondi M; Coperchini F; Pignatti P; Sideri R; Groppelli G; Leporati P; La Manna L; Magri F; Mariotti S; Chiovato L
J Clin Endocrinol Metab; 2013 Jan; 98(1):308-13. PubMed ID: 23118425
[TBL] [Abstract][Full Text] [Related]
7. Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.
Antonelli A; Ferrari SM; Fallahi P; Frascerra S; Santini E; Franceschini SS; Ferrannini E
J Clin Endocrinol Metab; 2009 May; 94(5):1803-9. PubMed ID: 19276231
[TBL] [Abstract][Full Text] [Related]
8. CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in Graves' and normal thyrocytes.
Antonelli A; Ferrari SM; Frascerra S; Pupilli C; Mancusi C; Metelli MR; Orlando C; Ferrannini E; Fallahi P
J Clin Endocrinol Metab; 2010 Dec; 95(12):E413-20. PubMed ID: 20810571
[TBL] [Abstract][Full Text] [Related]
9. Vanadium pentoxide prevents NK-92MI cell proliferation and IFNγ secretion through sustained JAK3 phosphorylation.
Gallardo-Vera F; Diaz D; Tapia-Rodriguez M; Fortoul van der Goes T; Masso F; Rendon-Huerta E; Montaño LF
J Immunotoxicol; 2016; 13(1):27-37. PubMed ID: 25565016
[TBL] [Abstract][Full Text] [Related]
10. The paramount role of cytokines and chemokines in papillary thyroid cancer: a review and experimental results.
Fallahi P; Ferrari SM; Piaggi S; Luconi M; Cantini G; Gelmini S; Elia G; Ruffilli I; Antonelli A
Immunol Res; 2018 Dec; 66(6):710-722. PubMed ID: 30617967
[TBL] [Abstract][Full Text] [Related]
11. Type I and type II interferons inhibit both basal and tumor necrosis factor-α-induced CXCL8 secretion in primary cultures of human thyrocytes.
Rotondi M; Coperchini F; Sideri R; Groppelli G; de Martinis L; Villani L; Pignatti P; Magri F; Chiovato L
J Interferon Cytokine Res; 2013 Sep; 33(9):508-13. PubMed ID: 23675779
[TBL] [Abstract][Full Text] [Related]
12. Metformin reverts the secretion of CXCL8 induced by TNF-α in primary cultures of human thyroid cells: an additional indirect anti-tumor effect of the drug.
Rotondi M; Coperchini F; Pignatti P; Magri F; Chiovato L
J Clin Endocrinol Metab; 2015 Mar; 100(3):E427-32. PubMed ID: 25590211
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of three CXC chemokines in Asian swamp eel (Monopterus albus) uncovers a third CXCL11_like group in fish.
Yuan H; Li Y; Panpan Han ; Tian G; Zhang W; Guo H; Xu Q; Wang T
Dev Comp Immunol; 2019 Dec; 101():103454. PubMed ID: 31326565
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease.
Antonelli A; Ferrari SM; Frascerra S; Corrado A; Pupilli C; Bernini G; Benvenga S; Ferrannini E; Fallahi P
Exp Cell Res; 2011 Jul; 317(11):1527-33. PubMed ID: 21565188
[TBL] [Abstract][Full Text] [Related]
15. Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathy.
Ferrari SM; Ragusa F; Paparo SR; Nasini F; Nardi M; Franceschini SS; Fallahi P; Antonelli A
Autoimmun Rev; 2019 Jul; 18(7):673-678. PubMed ID: 31059842
[TBL] [Abstract][Full Text] [Related]
16. Respiratory syncytial virus infection reduces lung inflammation and fibrosis in mice exposed to vanadium pentoxide.
Turpin EA; Antao-Menezes A; Cesta MF; Mangum JB; Wallace DG; Bermudez E; Bonner JC
Respir Res; 2010 Feb; 11(1):20. PubMed ID: 20175905
[TBL] [Abstract][Full Text] [Related]
17. Vanadium-induced chemokine mRNA expression and pulmonary inflammation.
Pierce LM; Alessandrini F; Godleski JJ; Paulauskis JD
Toxicol Appl Pharmacol; 1996 May; 138(1):1-11. PubMed ID: 8658498
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-α agonists modulate CXCL9 and CXCL11 chemokines in Graves' ophthalmopathy fibroblasts and preadipocytes.
Antonelli A; Ferrari SM; Frascerra S; Ruffilli I; Gelmini S; Minuto M; Pupilli C; Miccoli P; Sellari-Franceschini S; Ferrannini E; Fallahi P
Mol Cell Endocrinol; 2012 Feb; 349(2):255-61. PubMed ID: 22101320
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of CXCL8, CXCL10, CXCL11, CXCL12 and CXCL13 in serum and cerebrospinal fluid of patients with neuroborreliosis.
Moniuszko A; Czupryna P; Pancewicz S; Rutkowski K; Zajkowska O; Swierzbińska R; Grygorczuk S; Kondrusik M; Owłasiuk P; Zajkowska J
Immunol Lett; 2014; 157(1-2):45-50. PubMed ID: 24239846
[TBL] [Abstract][Full Text] [Related]
20. Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone.
Antonelli A; Ferrari SM; Fallahi P; Piaggi S; Paolicchi A; Franceschini SS; Salvi M; Ferrannini E
Metabolism; 2011 Feb; 60(2):277-83. PubMed ID: 20206950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
